COMMUNIQUÉS West-GlobeNewswire
-
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
10/07/2026 -
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
10/07/2026 -
Dubai Health and Rush University System for Health Announce Strategic Collaboration to Advance Quality of Care
10/07/2026 -
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
10/07/2026 -
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
10/07/2026 -
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
10/07/2026 -
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
10/07/2026 -
No easy answers: European research consortia take on major challenges
10/07/2026 -
UREVO Wins Red Dot Award 2026 for AI-Powered Wireless Recovery Boots
10/07/2026 -
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
10/07/2026 -
MindRank Announces $52 Million Series B Financing
10/07/2026 -
Cue Biopharma Announces $50.0 Million Private Placement
10/07/2026 -
Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026
10/07/2026 -
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
10/07/2026 -
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
09/07/2026 -
Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants
09/07/2026 -
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
09/07/2026 -
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
09/07/2026 -
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/07/2026
Pages